SG11201909765XA - An improved method for high level production of crm - Google Patents
An improved method for high level production of crmInfo
- Publication number
- SG11201909765XA SG11201909765XA SG11201909765XA SG11201909765XA SG 11201909765X A SG11201909765X A SG 11201909765XA SG 11201909765X A SG11201909765X A SG 11201909765XA SG 11201909765X A SG11201909765X A SG 11201909765XA
- Authority
- SG
- Singapore
- Prior art keywords
- hyderabad
- azamabad
- telangana
- limited
- biological
- Prior art date
Links
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1077—Pentosyltransferases (2.4.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Manufacture Of Electron Tubes, Discharge Lamp Vessels, Lead-In Wires, And The Like (AREA)
- Forging (AREA)
- Peptides Or Proteins (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 25 October 2018 (25.10.2018) WIP0 I PCT omit VIII °nolo om mil olo Ho Immo (10) International Publication Number WO 2018/193475 A2 (51) International Patent Classification: Not classified (21) International Application Number: PCT/IN2018/050235 (22) International Filing Date: 19 April 2018 (19.04.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 201741014335 22 April 2017 (22.04.2017) IN (71) Applicant: BIOLOGICAL E LIMITED [IN/IN]; 18/1 & 3, Azamabad, Hyderabad, Telangana, HYDERABAD 500020 (IN). (72) Inventors: MASILAMANI, Balamurali; Biological E Limited, 18/1 & 3, Azamabad, Hyderabad, Telangana, HY- DERABAD 500020 (IN). SRIRAMAN, Rajan; Biological E Limited, 18/1 & 3, Azamabad, Hyderabad, Telangana, HYDERABAD 500020 (IN). DIXIT, Mandar Shirish; Biological E Limited, 18/1 & 3, Azamabad, Hyderabad, Telangana, HYDERABAD 500020 (IN). CHAKKA, De- viprasanna; Biological E Limited, 18/1 & 3, Azamabad, Hyderabad, Telangana, HYDERABAD 500020 (IN). NAI- DU, Sureddisatyam; Biological E Limited, 18/1 & 3, Azamabad, Hyderabad, Telangana, HYDERABAD 500020 (IN). MATUR, Ramesh Venkat; Biological E Limited, 18/1 & 3, Azamabad, Hyderabad, Telangana, HYDER- ABAD 500020 (IN). MANTENA, Narender Dev; Biologi- cal E Limited, 18/1 & 3, Azamabad, Hyderabad, Telangana, HYDERABAD 500020 (IN). DATLA, Mahima; Biologi- cal E Limited, 18/1 & 3, Azamabad, Hyderabad, Telangana, HYDERABAD 500020 (IN). (74) Agent: MANDHANE, Ramachandra R.; Kayser & Com- pany, 2nd Floor Raja Bahadur Mansion, 20, Ambalal Doshi Marg, Fort, Mumbai, Maharashtra, MUMBAI 400001 (IN). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (54) Title: AN IMPROVED METHOD FOR HIGH LEVEL PRODUCTION OF CRM Overlap extend PCR 1XX Amp/median& cif:7197 diphtherteeATCC 53821 cassette from C. Amplification of eri/t cassette FIGURE 1 (57) : The present invention provides an improved method for the production of CRM197 with high yield using engineered 1-1 Corynebacterium diphtheria strain having increased copy number of CRM197 gene, wherein the method comprises growing the strain ei in a media free of animal derived components with one or more amino acids. O [Continued on next page] WO 2018/193475 A2 lilillEHEIMIRENOMOMBEEMEOlinii# SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: of inventorship (Rule 4.17 (iv)) Published: without international search report and to be republished upon receipt of that report (Rule 48.2(g)) in black and white; the international application as filed contained color or greyscale and is available for download from PATENTSCOPE
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201741014335 | 2017-04-22 | ||
PCT/IN2018/050235 WO2018193475A2 (en) | 2017-04-22 | 2018-04-19 | An improved method for high level production of crm |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201909765XA true SG11201909765XA (en) | 2019-11-28 |
Family
ID=63678648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201909765X SG11201909765XA (en) | 2017-04-22 | 2018-04-19 | An improved method for high level production of crm |
Country Status (30)
Country | Link |
---|---|
US (1) | US11098089B2 (en) |
EP (1) | EP3612553B1 (en) |
JP (1) | JP7161493B2 (en) |
KR (1) | KR102637436B1 (en) |
CN (1) | CN110741013B (en) |
AU (1) | AU2018255959B2 (en) |
BR (1) | BR112019022093A2 (en) |
CA (1) | CA3060723A1 (en) |
CL (1) | CL2019003003A1 (en) |
CO (1) | CO2019011643A2 (en) |
CU (1) | CU24668B1 (en) |
DK (1) | DK3612553T3 (en) |
EA (1) | EA201992527A1 (en) |
ES (1) | ES2926535T3 (en) |
HR (1) | HRP20221060T1 (en) |
HU (1) | HUE059629T2 (en) |
IL (1) | IL270075B1 (en) |
LT (1) | LT3612553T (en) |
MX (1) | MX2019012563A (en) |
MY (1) | MY194242A (en) |
PH (1) | PH12019550214A1 (en) |
PL (1) | PL3612553T3 (en) |
PT (1) | PT3612553T (en) |
RS (1) | RS63551B1 (en) |
SA (1) | SA519410306B1 (en) |
SG (1) | SG11201909765XA (en) |
SI (1) | SI3612553T1 (en) |
UA (1) | UA127497C2 (en) |
WO (1) | WO2018193475A2 (en) |
ZA (1) | ZA201906270B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113755380A (en) * | 2021-09-23 | 2021-12-07 | 艾美卫信生物药业(浙江)有限公司 | Strain culture medium for fermentation production of diphtheria toxin CRM197 protein, preparation method and strain recovery culture method |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69434079T2 (en) * | 1993-03-05 | 2005-02-24 | Wyeth Holdings Corp. | Plasmid for the production of CRM protein and diphtheria toxin |
US20040087020A1 (en) * | 1997-05-28 | 2004-05-06 | Chiron S.P.A. | Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin |
EP2199382A3 (en) | 1997-05-28 | 2010-09-22 | Novartis Vaccines and Diagnostics S.r.l. | Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin |
GB9904582D0 (en) | 1999-02-26 | 1999-04-21 | Nycomed Imaging As | Process |
EP1692269A4 (en) * | 2003-12-12 | 2007-09-26 | Sanofi Pasteur Ltd | Production of diphtheria toxin |
GB0505996D0 (en) * | 2005-03-23 | 2005-04-27 | Glaxosmithkline Biolog Sa | Fermentation process |
AU2010201410B2 (en) * | 2010-03-30 | 2015-04-30 | Pelican Technology Holdings, Inc. | High level expression of recombinant CRM197 |
GB2495341B (en) * | 2011-11-11 | 2013-09-18 | Novartis Ag | Fermentation methods and their products |
FR2992656B1 (en) * | 2012-07-02 | 2016-10-07 | Sanofi Pasteur | METHOD FOR PRODUCING ANTIGENS HAEMOPHILUS INFLUENZAE TYPE B |
ITMI20130142A1 (en) * | 2013-01-31 | 2014-08-01 | Biosynth Srl | GLYCOCOUGUGAR VACCINES INCLUDING BASIC UNITS OF AN EXPRIMENT MOLECULAR CONSTRUCTED MULTIPLE EPITHOPES INCORPORATED |
JP6473460B2 (en) * | 2014-03-03 | 2019-02-20 | スカラブ ゲノミクス, エルエルシー | Enhanced production of recombinant CRM197 in E. coli |
-
2018
- 2018-04-19 RS RS20220813A patent/RS63551B1/en unknown
- 2018-04-19 MX MX2019012563A patent/MX2019012563A/en unknown
- 2018-04-19 KR KR1020197033074A patent/KR102637436B1/en active IP Right Grant
- 2018-04-19 AU AU2018255959A patent/AU2018255959B2/en active Active
- 2018-04-19 HR HRP20221060TT patent/HRP20221060T1/en unknown
- 2018-04-19 LT LTEPPCT/IN2018/050235T patent/LT3612553T/en unknown
- 2018-04-19 SI SI201830744T patent/SI3612553T1/en unknown
- 2018-04-19 WO PCT/IN2018/050235 patent/WO2018193475A2/en active Application Filing
- 2018-04-19 HU HUE18773868A patent/HUE059629T2/en unknown
- 2018-04-19 CU CU2019000083A patent/CU24668B1/en unknown
- 2018-04-19 JP JP2019557469A patent/JP7161493B2/en active Active
- 2018-04-19 CA CA3060723A patent/CA3060723A1/en active Pending
- 2018-04-19 EP EP18773868.7A patent/EP3612553B1/en active Active
- 2018-04-19 ES ES18773868T patent/ES2926535T3/en active Active
- 2018-04-19 PL PL18773868.7T patent/PL3612553T3/en unknown
- 2018-04-19 US US16/606,958 patent/US11098089B2/en active Active
- 2018-04-19 UA UAA201911302A patent/UA127497C2/en unknown
- 2018-04-19 DK DK18773868.7T patent/DK3612553T3/en active
- 2018-04-19 IL IL270075A patent/IL270075B1/en unknown
- 2018-04-19 SG SG11201909765X patent/SG11201909765XA/en unknown
- 2018-04-19 BR BR112019022093A patent/BR112019022093A2/en unknown
- 2018-04-19 EA EA201992527A patent/EA201992527A1/en unknown
- 2018-04-19 CN CN201880026461.2A patent/CN110741013B/en active Active
- 2018-04-19 PT PT187738687T patent/PT3612553T/en unknown
- 2018-04-19 MY MYPI2019006169A patent/MY194242A/en unknown
-
2019
- 2019-09-23 ZA ZA2019/06270A patent/ZA201906270B/en unknown
- 2019-10-16 PH PH12019550214A patent/PH12019550214A1/en unknown
- 2019-10-16 SA SA519410306A patent/SA519410306B1/en unknown
- 2019-10-21 CL CL2019003003A patent/CL2019003003A1/en unknown
- 2019-10-21 CO CONC2019/0011643A patent/CO2019011643A2/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201805835WA (en) | Modified oncolytic virus | |
SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
SG11201901841TA (en) | Targeting ligands | |
SG11201909777YA (en) | Modulatory polynucleotides | |
SG11201901077RA (en) | Anti-tigit antibodies, anti-pvrig antibodies and combinations thereof | |
SG11201901506VA (en) | Distributed systems for the efficient production and use of microbe-based compositions | |
SG11201909432SA (en) | Compounds for increasing genome editing efficiency | |
SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
SG11201804161VA (en) | Compositions comprising bacterial strains | |
SG11201909011PA (en) | Niraparib compositions | |
SG11201906225PA (en) | Maintenance and expansion of pancreatic progenitor cells | |
SG11201407902YA (en) | Methods and compositions for biomethane production. | |
SG11201810757YA (en) | Non-human animals expressing exogenous terminal deoxynucleotidyltransferase | |
SG11201804997XA (en) | Process for preparing non-cariogenic, sustained energy release juice | |
SG11201908325PA (en) | Process for the preparation of glucuronide drug-linkers and intermediates thereof | |
SG11201907685TA (en) | Compositions and methods for robust dynamic metabolic control | |
SG11201807523PA (en) | Ilt7 binding molecules and methods of using the same | |
SG11201906359SA (en) | Compositions and methods for maturation of oocytes in vitro | |
SG11201810019RA (en) | Methods of human leukocyte antigen typing | |
SG11201808592PA (en) | Method for selection of high m6p recombinant proteins | |
SG11201908765RA (en) | Apparatus having a flexible led display module and a method of employing same | |
SG11201806393QA (en) | Use of gabaa receptor modulators for treatment of itch | |
SG11201901188VA (en) | Metal powder feedstocks for additive manufacturing, and system and methods for producing the same | |
SG11201901172QA (en) | A method for manufacturing a fuel component |